the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010.
.
suven life sciences' pashamylaram facility successfully completes usfda inspection
.
.
.
aurobindo pharma's arm recalls 2 antibiotic injections from us
.
.